The neomorphic E3 ligase activity of CRL4CRBN is induced by the binding of IMiDs to CRBN, and CRBN deficiency in a human multiple myeloma cell line confers resistance to IMiDs8,9,15. Here, CRBN is linked to plasma cell myeloma.